AdChem

Adjuvant technologies for livestock, poultry and aquaculture vaccines.

ADCHEM supplies and supports specialised vaccine adjuvant systems for manufacturers of veterinary biologics across the Middle East, Türkiye, North Africa and South Asia. Our focus is not simply on supplying an ingredient. We work with vaccine manufacturers to identify the appropriate adjuvant chemistry for the target species, antigen, vaccine format and route of administration, while supporting the regulatory documentation and supply chain required for commercial production.

A specialised category at the frontier of animal health.

Animal vaccine adjuvants sit somewhere between pharmaceutical excipients and veterinary biologics.

Unlike a conventional functional excipient, the choice of adjuvant can directly influence the strength, duration and character of the immune response, while also affecting factors such as injection-site tolerance, emulsion stability and antigen compatibility.

That makes adjuvant selection an early formulation decision rather than simply a procurement exercise.

ADCHEM works with veterinary vaccine manufacturers from initial evaluation and sample quantities through development, scale-up and commercial supply.

01

Aquaculture vaccines

Aquaculture introduces a very different set of vaccination challenges from terrestrial livestock.
Depending on species, life stage and production system, vaccination may involve individual injection or scalable approaches such as immersion, mucosal and oral delivery.
ADCHEM supports adjuvant technologies for major farmed species including:

Tilapia · Salmonids · Pangasius · Carp

02

Poultry & mass vaccination

Commercial poultry programmes require vaccination at a completely different scale.
Alongside injectable inactivated vaccines, manufacturers may be developing vaccines for in-ovo, spray, drinking-water or other mass-administration routes, each with different formulation and delivery requirements.
ADCHEM supports adjuvant selection across:

Broilers · Layers · Breeders · Turkeys

03

Swine vaccine adjuvants

For swine vaccines, adjuvant performance must be balanced against practical considerations including immune-response duration, injection-site tolerance and compatibility with multivalent antigen systems.
ADCHEM supports adjuvant technologies for:

Sows · Piglets · Fattening programmes

04

Ruminant vaccine adjuvants

Across bacterial and viral vaccine systems relevant to production animals.
Depending on the application, this can include oil-in-water, water-in-oil and other emulsion or mineral-based adjuvant systems, selected according to the antigen, required immune profile and target species.
ADCHEM supports vaccine-development programmes for:

Cattle · Sheep · Goats · Camelids

Adjuvant systems by
species and delivery route.

01 / 05 · Featured

Aquaculture

Adjuvant and delivery technologies for farmed-fish vaccines, ranging from injectable formulations for individual vaccination to systems designed for mucosal, immersion or oral administration.

Injectable

Mucosal

Oral

Mass delivery

03 / 05

Poultry

Adjuvant systems for injectable inactivated vaccines together with technologies suitable for large-scale poultry vaccination programmes.

Injectable

In-ovo

Mucosal

Mass vaccination

03/ 05

Swine

Adjuvant technologies for bacterial and viral vaccines, including commercial and autogenous formulations.

Oil emulsions

Mineral systems

Autogenous

Multivalent

04 / 05

Ruminant

Adjuvant systems for cattle, sheep, goats and camelids, selected according to the antigen system, desired immune response and production requirements.

Oil-in-water

Water-in-oil

Mineral

Injectable

05 / 05

Development & Technical Services

For programmes requiring more than standard product selection, ADCHEM can coordinate technical support with specialised development partners.

Custom formulation

Efficacy studies

Safety studies

Immunological testing

Scale-up support

Specialist technologies. One regional ADCHEM partner.

Ictyodev is the principal behind every ADCHEM animal vaccine adjuvant — a small, specialised French laboratory with regulatory pedigree and scientific depth that very few organisations in this category can match.

ADCHEM

"An independent French animal-health laboratory specialising in vaccine adjuvants for all production animals, with deep expertise in aquaculture."

Combined century of adjuvant expertise — and the only tilapia CRO in the world.

Veterinary vaccine adjuvants are a highly specialised part of the raw-materials industry. ADCHEM therefore works with manufacturers and technical partners selected specifically for their expertise in veterinary biologics, adjuvant chemistry and pharmaceutical-grade production.

Our role is to bring those technologies closer to vaccine manufacturers in the markets we serve — commercially, technically and operationally.

Rather than asking customers to manage separate relationships with overseas manufacturers, logistics providers and local regulatory teams, ADCHEM provides a regional point of coordination from initial evaluation through commercial supply.

Technologies & services

Area
Injectable Adjuvants
ADCHEM capability

Oil-emulsion, mineral and other specialised adjuvant systems

Typical application
Poultry, swine, ruminants, aquaculture
Area
Aquaculture Adjuvants
ADCHEM capability

Technologies developed around the vaccination requirements of farmed fish

Typical application
Tilapia, salmonids, pangasius, carp
Area
Mass-Delivery Systems
ADCHEM capability

Technologies suitable for non-traditional administration routes

Typical application
Poultry and aquaculture
Area
Autogenous Vaccines
ADCHEM capability

Adjuvant selection for farm- or region-specific vaccine programmes

Typical application
Poultry, swine, ruminants
Area
Custom Development
ADCHEM capability

Technical coordination for projects requiring tailored adjuvant systems

Typical application
New antigens, multivalent vaccines, novel delivery routes
Area
Technical Studies
ADCHEM capability

Access to specialist efficacy, safety and immunological evaluation through development partners

Typical application
Vaccine development and qualification

Area

ADCHEM capability

Typical application

Injectable Adjuvants

Oil-emulsion, mineral and other specialised adjuvant systems

Poultry, swine, ruminants, aquaculture

Aquaculture Adjuvants

Technologies developed around the vaccination requirements of farmed fish

Tilapia, salmonids, pangasius, carp

Mass-Delivery Systems

Technologies suitable for non-traditional administration routes

Poultry and aquaculture

Autogenous Vaccines

Adjuvant selection for farm- or region-specific vaccine programmes

Poultry, swine, ruminants

Custom Development

Technical coordination for projects requiring tailored adjuvant systems

New antigens, multivalent vaccines, novel delivery routes

Technical Studies

Access to specialist efficacy, safety and immunological evaluation through development partners

Vaccine development and qualification

Application

Aquaculture

Adjuvant systems supporting injectable and mass-delivery vaccination programmes for commercially farmed fish.

Poultry

Technologies for injectable vaccines as well as in-ovo and other mass-vaccination approaches.

Inactivated bacterial & viral vaccines

Adjuvant systems selected to enhance and prolong the immune response of inactivated veterinary vaccines.

Autogenous vaccines

Support for vaccine programmes developed around farm-specific or geographically relevant pathogen strains.

Mucosal & oral delivery

Specialised approaches for programmes where vaccination by injection is impractical at commercial scale.

Development-stage vaccines

Technical support for manufacturers evaluating new antigens, combinations, species or administration routes.

Quality starts before the material ships.

Veterinary vaccine manufacturers need considerably
more than a commercial specification.
ADCHEM evaluates adjuvant suppliers around
manufacturing controls, batch consistency, traceability,
supporting technical data and the regulatory
documentation required by the destination market.

ISO 9001:2015
Quality Management Systems

ISO 9001:2015 certification (achieved 2022) for the manufacture of excipients for veterinary products — covering the full ICTYOLANE® adjuvant production process.

EXCiPACT®
Excipient GMP/GDP Certification

EXCiPACT® certification (2023) for oil excipients used in pharmaceutical products — the leading global certification standard for pharmaceutical excipient manufacturers.

GMP — Aquatic
Veterinary Vaccine Batch Release

GMP certification for aquatic veterinary vaccine batch release — a rare qualification enabling Ictyodev to act as a contract manufacturer for vaccine developers requiring GMP-certified batch release.

GLP
Good Laboratory Practice

All Ictyodev research studies — efficacy, safety, and challenge trials — are conducted under GLP guidelines, with full study design, raw data, and final report for regulatory submission.

Kosher Certification

ADCHEM holds ISO 9001:2015, EXCiPACT®, GMP, and GDP certification across our pharmaceutical and biologics distribution operations. For Ictyodev adjuvants, ADCHEM maintains cold-chain capability across applicable routes and provides full documentation (CoA, SDS, regulatory support letter) with every order via COSMO.

Documentation supplied with every order

Depending on the product and manufacturer, available documentation
may include:

Standard
Standard
Standard
Standard
On request
On request
On request

Our regional regulatory and quality teams then support the documentation required for qualification and importation in the markets we serve.

Local knowledge matters in veterinary biologics.

Veterinary biologics are regulated locally, and requirements can vary significantly between markets.

ADCHEM combines the manufacturer's technical dossier with support from teams operating within the region.

ADCHEM active markets — animal vaccines

Egypt & North Africa

Commercial and regulatory coordination through ADCHEM Egypt for vaccine manufacturers across Egypt and neighbouring North African markets.

Türkiye

Local support through ADCHEM İstanbul for Turkish veterinary and animal-health manufacturers.

Gulf

ADCHEM Dubai coordinates supply and regulatory documentation for customers across the UAE and wider GCC.

South Asia

Our Lahore, Karachi and Islamabad teams support veterinary manufacturers across Pakistan and the wider South Asian market. We work the government and the private sector to bring the latest adjuvant technologies to their doorstep.

01

Technical conversations, not catalogue selling

Adjuvant selection involves antigen compatibility, emulsion behaviour, administration route, target species and desired immune response.
ADCHEM's role is to understand enough of the application to bring the right technical resources into the discussion — rather than simply forwarding a product list.

02

Supply continuity

Once an adjuvant is incorporated into an approved vaccine formulation, changing material or losing supply can become a much bigger problem than an ordinary raw-material stock-out.
ADCHEM therefore works with customers on forecasting, regional stock positioning and longer-term supply planning for commercial vaccine programmes.

03

Regional regulatory support

Our teams understand that veterinary product requirements differ between Egypt, Türkiye, the Gulf and South Asia.
ADCHEM helps coordinate manufacturer documentation with the regulatory requirements of the destination market.

04

Visibility through COSMO

Orders, documentation and logistics are managed through COSMO, ADCHEM's proprietary platform, giving our regional teams a common view of the customer's requirements and supply history.

Request a Sample

    Tell us what you are looking for, and our team will help you identify the right ingredient, specification and sample for evaluation.

    A specialised ingredient.
    A regional team that
    understands it.

    ADCHEM supports veterinary vaccine manufacturers across the Middle East, Türkiye, North Africa and South Asia with specialised adjuvant technologies, technical coordination, regulatory support and regional supply.

    Whether you are evaluating an adjuvant for an existing vaccine, developing a new formulation or looking for an alternative supply source, speak to our animal-health team.

    Scroll to Top